Patient Registry Software Market Analysis by Type, Deployment & Region
The global patient registry software market was valued at $993.3 million in 2021, and is projected to reach $2,508.27 million by 2031
According to the report published by Allied Market Research, the Global Patient Registry Software Market generated $993.3 million in 2021, and is estimated to reach $2.50 billion by 2031, witnessing a CAGR of 9.7% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.
The report offers detailed a segmentation of the global patient registry software market based on registry type, software type, functionality, end user, and region. The report provides an analysis of each segment and sub-segment with the help of tables and figures. This analysis helps market players, investors, and new entrants in determining the sub-segments to be tapped on to achieve growth in the coming years.
Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2825
Based on registry type, the disease registry segment held the largest share in 2021, contributing to nearly three-fifths of the global patient registry software market, and is likely to maintain its leadership status during the forecast period. Moreover, the same segment is expected to manifest the highest CAGR of 10.3% from 2022 to 2031.
Based on software type, the integrated segment held the largest share in 2021, accounting for nearly three-fifths of the global patient registry software market, and would rule the roost through 2031. Moreover, the same segment is estimated to witness the fastest CAGR of 10.3% during the forecast period.
Based on end user, the government and third party organizations segment was the largest in 2021, accounting for around one-third of the global patient registry software market, and is likely to maintain its leadership status during the forecast period. However, the pharma, biotech and medical device companies segment is expected to manifest the highest CAGR of 11.2% from 2022 to 2031.
Based on region, the market in North America accounted for more than half of the global patient registry software market in 2021, and is likely to maintain its leadership status during the forecast period. However, the Asia-Pacific market is expected to manifest the highest CAGR of 11.3% from 2022 to 2031.
Leading players of the global patient registry software market analyzed in the research include Conduent, Inc., Dacima Software Inc., Elekta AB (pub), FIGmd, Inc., IBM Corp, ImageTrend Inc., IQVIA Holdings, McKesson Corporation, OpenText Corporation, Optum, Inc., Ordinal Data, Inc., and Premier, Inc.
The report analyzes these key players of the global patient registry software market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Read More:
surgical microscopes market medical lifting sling market erythropoietin drugs market genotyping market animal model market